Bryan C. Barnhart

Person

Philadelphia, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,952,427
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 11,524,992
- Issue date Dec 13, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against CD73 and uses thereof
- Patent number 11,352,440
- Issue date Jun 7, 2022
- Bristol-Myers Squibb Company
- Nils Lonberg
- G01 - MEASURING TESTING
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,306,149
- Issue date Apr 19, 2022
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 11,213,586
- Issue date Jan 4, 2022
- Bristol-Myers Squibb Company
- Changyu Wang
- G01 - MEASURING TESTING
Information Patent Grant
Combination of DR5 agonist and anti-PD-1 antagonist and methods of use
- Patent number 11,103,579
- Issue date Aug 31, 2021
- Bristol-Myers Squibb Company
- Bryan Barnhart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding an anti-CD40 antibody
- Patent number 10,844,130
- Issue date Nov 24, 2020
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies comprising modified heavy constant regions
- Patent number 10,653,791
- Issue date May 19, 2020
- Bristol-Myers Squibb Company
- Nils Lonberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 10,584,160
- Issue date Mar 10, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to CD40 with enhanced agonist activity
- Patent number 10,479,838
- Issue date Nov 19, 2019
- Bristol-Myers Squibb Company
- Jeffrey V. Ravetch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against CD73
- Patent number 10,167,343
- Issue date Jan 1, 2019
- Bristol-Myers Squibb Company
- Nils Lonberg
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies against CD73 and uses thereof
- Patent number 10,100,129
- Issue date Oct 16, 2018
- Bristol-Myers Squibb Company
- Nils Lonberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against CD73
- Patent number 9,605,080
- Issue date Mar 28, 2017
- Bristol-Myers Squibb Company
- Nils Lonberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES AGAINST CD73 AND USES THEREOF
- Publication number 20230051701
- Publication date Feb 16, 2023
- Bristol-Myers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40 ANTIBODIES AND USES THEREOF
- Publication number 20220324989
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE
- Publication number 20220098302
- Publication date Mar 31, 2022
- Bristol-Myers Squibb Company
- Bryan Barnhart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40 ANTIBODIES AND USES THEREOF
- Publication number 20200339700
- Publication date Oct 29, 2020
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS
- Publication number 20200299400
- Publication date Sep 24, 2020
- Bristol-Myers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS
- Publication number 20200268901
- Publication date Aug 27, 2020
- Bristol-Myers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200262893
- Publication date Aug 20, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY
- Publication number 20200071412
- Publication date Mar 5, 2020
- THE ROCKEFELLER UNIVERSITY
- Jeffrey V. Ravetch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH ANTI-CD73 ANTIBODIES
- Publication number 20190284293
- Publication date Sep 19, 2019
- Bristol-Myers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD40
- Publication number 20190248911
- Publication date Aug 15, 2019
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20190077844
- Publication date Mar 14, 2019
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD73 AND USES THEREOF
- Publication number 20190062456
- Publication date Feb 28, 2019
- Bristol-Myers Squibb Company
- Nils LONBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST CD73 AND USES THEREOF
- Publication number 20190055320
- Publication date Feb 21, 2019
- Bristol-Myers Squibb Company
- Nils LONBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE
- Publication number 20180360962
- Publication date Dec 20, 2018
- Bristol-Myers Squibb Company
- Bryan Barnhart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...
- Publication number 20180339042
- Publication date Nov 29, 2018
- Bristol-Myers Squibb Company
- Changyu WANG
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS
- Publication number 20180333502
- Publication date Nov 22, 2018
- Bristol-Myers Squibb Company
- Nils LONBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST OX40 AND USES THEREOF
- Publication number 20180237534
- Publication date Aug 23, 2018
- Bristol-Myers Squibb Company
- Zhehong CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD40
- Publication number 20180142030
- Publication date May 24, 2018
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD73 AND USES THEREOF
- Publication number 20180127513
- Publication date May 10, 2018
- Bristol-Myers Squibb Company
- Nils LONBERG
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST CD73
- Publication number 20170253665
- Publication date Sep 7, 2017
- Bristol-Myers Squibb Company
- Nils LONBERG
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY
- Publication number 20160376371
- Publication date Dec 29, 2016
- THE ROCKEFELLER UNIVERSITY
- Jeffrey V. Ravetch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST OX40 AND USES THEREOF
- Publication number 20160347849
- Publication date Dec 1, 2016
- Bristol-Myers Squibb Company
- Zhehong CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD73 AND USES THEREOF
- Publication number 20160145350
- Publication date May 26, 2016
- Bristol-Myers Squibb Company
- Nils Lonberg
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE
- Publication number 20160067337
- Publication date Mar 10, 2016
- Bristol-Myers Squibb Company
- Bryan BARNHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PRO...
- Publication number 20110123545
- Publication date May 26, 2011
- Bristol -Myers Squibb Company
- H. Nicholas Marsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Bryan C. Barnhart

Person

Patents Grantslast 30 patents

Anti-CD40 antibodies and uses thereof

Glypican-3-binding fibronectin based scaffold molecules

Antibodies against CD73 and uses thereof

Anti-CD40 antibodies and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Combination of DR5 agonist and anti-PD-1 antagonist and methods of use

Nucleic acids encoding an anti-CD40 antibody

Antibodies comprising modified heavy constant regions

Glypican-3-binding fibronectin based scaffold molecules

Antibodies to CD40 with enhanced agonist activity

Antibodies against CD73

Antibodies against CD73 and uses thereof

Antibodies against CD73

Patents Applicationslast 30 patents

ANTIBODIES AGAINST CD73 AND USES THEREOF

ANTI-CD40 ANTIBODIES AND USES THEREOF

COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE

ANTI-CD40 ANTIBODIES AND USES THEREOF

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

COMBINATION THERAPY WITH ANTI-CD73 ANTIBODIES

ANTIBODIES TO CD40

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

ANTIBODIES AGAINST CD73 AND USES THEREOF

ANTIBODIES AGAINST CD73 AND USES THEREOF

COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

ANTIBODIES AGAINST OX40 AND USES THEREOF

ANTIBODIES TO CD40

ANTIBODIES AGAINST CD73 AND USES THEREOF

ANTIBODIES AGAINST CD73

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

ANTIBODIES AGAINST OX40 AND USES THEREOF

ANTIBODIES AGAINST CD73 AND USES THEREOF

COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE

COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PRO...